Demographic, Clinical, and Laboratory Characteristics of HIV Patients with Cerebral Toxoplasmosis at Haji Adam Malik General Hospital Medan


  • Alfansuri Kadri North Sumatera University
  • Eko Yandra North Sumatera University



Cerebral toxoplasmosis, clinical characteristics, HIV, patient characteristics


Cerebral toxoplasmosis is one of the frequent opportunistic infections of the central nervous system of Human Immunodeficiency Virus (HIV) patients in the presence of Toxoplasma Gondii infection. In Indonesia, the incidence of HIV patients with cerebral toxoplasmosis is 45%. This study was done to determine the demographic, clinical, and laboratory characteristics of HIV patients with cerebral toxoplasmosis at Haji Adam Malik Hospital, Medan, based on medical record data in 2022. The total sample was 23 patients with time periods from January to March 2022. Demographically, the data showed that most of the HIV patients with cerebral toxoplasmosis were male (91.3%), a mean age of 36.48 ± 5.74 years, married (87%), high school graduates (69.6%), and working (91.3%). The most common clinical characteristics were headache (69.6%) and cognitive impairment (56.5%). Laboratory characteristics found were (56.5%) non-reactive (<0.8 COI) and (43.5%) reactive (≥1 COI) anti toxoplasma IgM, while reactive anti-toxoplasma IgG (≥3 IU/ml) was obtained in all research samples (100%).


Download data is not yet available.


Fitri FI, Rambe AS, and Fitri A. Correlation between Lymphocyte CD4 Count, Treatment Duration, Opportunistic Infection and Cognitive Function in Human Immunodeficiency Virus-Acquired Immunodeficiency Syndrome (HIV-AIDS) Patients. Macedonian Journal of Medical Sciences. 2018; 6(4): 643-647.

Dinas Kesehatan Sumut. Profil Kesehatan Provinsi Sumatera Utara Tahun 2017. Medan. (Online) 2017.

Basavaraju A. Toxoplasmosis in HIV infection. An Overview. Tropical Parasitology. 2016; 6(2): 129–135.

Yuliawati I and Nasronudin. Pathogenesis, Diagnostic, and Management of Toxoplasmosis. Indonesian Journal of Tropical and Infectious Disease. 2015; 5(4): 101-106.

Lau A, Jain MK, Chow JYS, Kitchell E, Lazarte S, and Nijhawan A. Toxoplasmosis Encephalitis: A Cross Sectional Analysis at U.S. Safety-Net Hospital in the Late cART Era. Journal of the International Association of Providers of AIDS Care. 2021; 20: 1-7.

Sukarini NP, Sudewi AAR, and Laksmidewi AAAP. Kadar CD4 sebagai Faktor Risiko Gangguan Kognitif pada Penderita Human Immunodeficiency Virus Pra-Antiretroviral. Majalah Kedokteran Neurosains. 2017; 34(2): 73- 75.

Ismayani K, Suharjanti I, and Sugianto P. Korelasi antara Kadar CD4 Dengan Skala Karnofsky pada Penderita AIDS dengan Toksoplasmosis Serebri. Neurona. 2012; 30(1): 1-5.

Hassana DS, Hadisaputro S, and Sofro MAU. Toxoplasmosis and Cerebral Toxoplasmosis in HIV/AIDS Patients in Kariadi Hospital, Semarang. Jurnal Epidemiologi Kesehatan Komunitas. 2021; 6(1): 213-217.

Pimpalkar S, Mishra M, Kurhade A, Unakal C, Kurhade G, and Powar R. Prevalence of Toxoplasmosis among HIV/AIDS Patients and Correlation of Radiological Investigations with Laboratory Findings. Microbiology Research Journal International. 2018; 26(3): 1-10.

Firouzeh MM, Moradbeigi M, Seyedalinagi S, et al. Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted Into Imam Khomeini Hospital of Tehran, Iran. Infectious Disorders-Drug Target. 2016; 16(2): 113–120.

Blader IJ, Coleman BJ, Tichen C, and Gubbels MJ. Lytic Cycle of Toxoplasma gondii: 15 Years Later. Annual Review of Microbiology. 2015; 69: 463-485.

Luma HL, Tchaleu BCN, Mapoure YN, et al. Toxoplasma encephalitis in HIV/AIDS Patients Admitted to the Douala General Hospital between 2004 and 2009: A Cross Sectional Study. BioMedCentral Research Note. 2013; 6: 1–5.



2022-08-31 — Updated on 2022-11-04




Research Article